KLI

Login OAK 국가리포지터리
검색

Ulsan Univ. Repository Journal Papers Medicine Nursing

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B)

Metadata Downloads
Abstract
We investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma®, in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.
Author(s)
Sung Hoon Sim; Jeong Eun Kim; Min Hwan Kim; Yeon Hee Park; Jee Hyun Kim; Koung Jin Suh; Su-Jin Koh; Kyong Hwa Park; Myoung Joo Kang; Mi Sun Ahn; Kyoung Eun Lee; Hee-Jun Kim; Hee Kyung Ahn; Han Jo Kim; Keon Uk Park; Jae Ho Byun; Jin Hyun Park; Gyeong-Won Lee; Keun Seok Lee; Joohyuk Sohn; Kyung Hae Jung; In Hae Park
Issued Date
2022
Type
Article
Keyword
Clinical trial; HER2 positive; Metastatic breast cancer; Trastuzumab biosimilar; ctDNA
DOI
10.1016/j.breast.2022.08.002
URI
https://oak.ulsan.ac.kr/handle/2021.oak/14137
Publisher
BREAST
Language
영어
ISSN
0960-9776
Citation Volume
65
Citation Number
0
Citation Start Page
172
Citation End Page
178
Appears in Collections:
Medicine > Nursing
공개 및 라이선스
  • 공개 구분공개
파일 목록

  • 관련 파일이 존재하지 않습니다.

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.